{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:50:15Z","timestamp":1768711815266,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.clinthera.2006.04.007","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T17:13:22Z","timestamp":1149700402000},"page":"552-559","source":"Crossref","is-referenced-by-count":44,"title":["A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension"],"prefix":"10.1016","volume":"28","author":[{"given":"Ricardo","family":"Reis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos F.","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos P.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopoldo","family":"Magacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.04.007_bib1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","author":"The AGIS Investigators","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0161-6420(82)34675-8","article-title":"Why do some people go blind from glaucoma?","volume":"89","author":"Grant","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clinthera.2006.04.007_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-9394(99)00387-6","article-title":"Intraocular pressure and progression of glaucomatous visual field loss","volume":"129","author":"Martinez-Bello","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0002-9394(01)01188-6","article-title":"Influence of surgical reduction of intraocular pressure on regions of the visual field with different levels of sensitivity","volume":"132","author":"Salim","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","article-title":"The Ocular Hypertension Treatment Study: Design and baseline description of the participants","volume":"117","author":"Gordon","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0161-6420(00)00021-X","article-title":"Target pressure-glaucomatologists' holey grail","volume":"107","author":"Singh","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clinthera.2006.04.007_bib9","author":"Shields","year":"2000"},{"key":"10.1016\/j.clinthera.2006.04.007_bib10","series-title":"Travoprost Ophthalmic Solution 0.004%","first-page":"1","year":"2001"},{"key":"10.1016\/j.clinthera.2006.04.007_bib11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.clinthera.2004.12.006","article-title":"Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open angle glaucoma: A randomized, controlled, investigatorblinded study","volume":"26","author":"Reis","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2006.04.007_bib12","series-title":"Poster presented at: The International Congress of Ophthalmology","article-title":"Long-term effect of latanoprost on intraocular pressure","author":"Hedman","year":"1998"},{"key":"10.1016\/j.clinthera.2006.04.007_bib13","series-title":"Presented at: American Glaucoma Society Annual Meeting","article-title":"Frequency of adjunctive medication use associated with bimatoprost, travoprost and latanoprost therapy","author":"Robin","year":"2003"},{"key":"10.1016\/j.clinthera.2006.04.007_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0039-6257(80)90045-4","article-title":"Compliance with ocular therapy","volume":"24","author":"Ashburn","year":"1980","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-199201020-00012","article-title":"Compliance with medical treatment of glaucoma","volume":"1","author":"Weinreb","year":"1992","journal-title":"J Glaucoma"},{"key":"10.1016\/j.clinthera.2006.04.007_bib16","series-title":"Patient Compliance in Medical Practice and Clinical Trials","first-page":"3","article-title":"Overview of methods to measure and enhance patient compliance","author":"Cramer","year":"1991"},{"key":"10.1016\/j.clinthera.2006.04.007_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0039-6257(83)90142-X","article-title":"Facilitating patient compliance in glaucoma therapy","volume":"28","author":"Zimmerman","year":"1983","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","article-title":"Travoprost compared with latanoprost and timolol in patients with open-angle glauco ma or ocular hypertension","volume":"132","author":"Netland","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib19","author":"Timolol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib20","author":"Brinzolomide"},{"key":"10.1016\/j.clinthera.2006.04.007_bib21","author":"Brimonidine"},{"key":"10.1016\/j.clinthera.2006.04.007_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archopht.1957.00940010526005","article-title":"Width and pigmentation of the angle of the anterior chamber. A system of grading by gonioscopy","volume":"58","author":"Scheie","year":"1957","journal-title":"AMA Arch Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib23","series-title":"Automated Static Perimetry","author":"Anderson","year":"1999"},{"key":"10.1016\/j.clinthera.2006.04.007_bib24","series-title":"The Optic Nerve in Glaucoma","year":"1993"},{"key":"10.1016\/j.clinthera.2006.04.007_bib25","first-page":"1315","article-title":"Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep","volume":"26","author":"Topper","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clinthera.2006.04.007_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1475-1313.1993.tb00491.x","article-title":"Investigation of parameters influencing intraocular pressure increases during sleep","volume":"13","author":"Wildsoet","year":"1993","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.clinthera.2006.04.007_bib27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archopht.1987.01060080114039","article-title":"Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoescleral outflow by prostaglandin F2 alpha","volume":"105","author":"Crawford","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0161-6420(80)35263-9","article-title":"Interim report: National Registry of possible drug-induced ocular side effects","volume":"87","author":"Fraunfelder","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clinthera.2006.04.007_bib29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0002-9394(84)90250-2","article-title":"Ocular beta-blockers and systemic effects","volume":"98","author":"Van Buskirk","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib30","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0002-9394(02)01418-6","article-title":"Additive intraocular pressure lowering effect of various medications with latanoprost","volume":"133","author":"O'Connor","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0002-9394(86)90942-6","article-title":"A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma","volume":"101","author":"Allen","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clinthera.2006.04.007_bib32","first-page":"43","article-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Hardman","year":"1996"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T20:55:14Z","timestamp":1547585714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0149291806000956"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.04.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}